Studies to date have shown an association between the presence of patent foramen ovale and cryptogenic stroke in patients younger than 55 years of age. This association has not been established in ...
The options for secondary prevention of cryptogenic embolism in patients with patent foramen ovale are administration of antithrombotic medications or percutaneous closure of the patent foramen ovale.
Discover the latest articles and news in related subjects. Here we describe a new three-generation family segregating PFMCCD in four affected individuals. A heterozygous frameshift mutation in MSX2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results